SEC Form 4 · accession 0001493152-26-028884
Dermata Therapeutics, Inc. · DRMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathleen D. Scott
Director
Period of report
Jun 16, 2026
Accepted (ET)
Jun 16, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001853816
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 16, 2026 | S | 11 | $1.1901 | D | 0 | D | |
| Common Stock | holding | — | — | — | 1 | I | By Scott 2008 Trust Dated 3/28/08 |
Table II — derivative securities
No Table II lines on this filing.